Preferred Label : baloxavir;
CISMeF synonym : 10.1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazine-6,8-dione, 12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-3,4,12,12a-tetrahydro-7-hydroxy-,
(12aR)-;
MeSH synonym : (12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,e)thiepin-11-yl)-7-hydroxy-3,4,12,12a-tetrahydro-1h-(1,4)oxazino(3,4-c)pyrido(2,1-f)(1,2,4)triazine-6,8-dione;
MeSH hyponym : (((12aR)-12-((11S)-7,8-difluoro-6,11-dihydrodibenzo(b,E)thiepin-11-yl)-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-(1,4)oxazino(3,4-C)pyrido(2,1-F)(1,2,4)triazin-7-yl)oxy)methyl
methyl carbonate;
MeSH Related Number : 505CXM6OHG;
UNII : 4G86Y4JT3F;
Origin ID : C000628402;
UMLS CUI : C4734224;
ATC code(s)
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
https://www.ema.europa.eu/en/medicines/human/EPAR/xofluza
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug approval
europe
baloxavir marboxil
baloxavir marboxil
baloxavir marboxil
antiviral agents
antiviral agents
enzyme inhibitors
enzyme inhibitors
product surveillance, postmarketing
administration, oral
adolescent
adult
aged
influenza, human
influenza, human
Post-Exposure prophylaxis
drug interactions
pregnancy
breast feeding
prodrugs
endonucleases
drug evaluation, preclinical
Product containing only baloxavir marboxil in oral dose form (medicinal product form)
baloxavir
baloxavir
oxazines
pyridines
thiepins
triazines
oxazines
pyridines
thiepins
triazines
---